Institutions Bob Young: NCCN is a case study in keeping what works and discarding what doesn’t By The Cancer Letter March 12, 2021
Institutions NCCN’s Bob Carlson talks about the day he stormed out of a meeting with transplanters By The Cancer Letter March 26, 2021
Institutions Bill McGivney: How NCCN guidelines came to play a role in payment for cancer therapy By The Cancer Letter March 19, 2021
Primary SourceSpotlight Article Iressa: Oncologic Drugs Advisory Committee Meeting Sept. 24, 2002 By FDA Oncology Center of Excellence
Primary SourceSpotlight Article Waun Ki Hong, M.D. Oral History Interview, 2013 By MD Anderson Cancer Center